nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisinopril—Pulmonary eosinophilia—Dapsone—leprosy	0.0618	0.0771	CcSEcCtD
Lisinopril—Anxiety depression—Thalidomide—leprosy	0.0352	0.0439	CcSEcCtD
Lisinopril—Pain in arm—Thalidomide—leprosy	0.0352	0.0439	CcSEcCtD
Lisinopril—ACE—hindlimb—leprosy	0.0314	0.158	CbGeAlD
Lisinopril—ACE—arm—leprosy	0.0299	0.151	CbGeAlD
Lisinopril—ACE—appendage—leprosy	0.0269	0.136	CbGeAlD
Lisinopril—ACE—peripheral nervous system—leprosy	0.0245	0.123	CbGeAlD
Lisinopril—ACE—nerve—leprosy	0.0191	0.0963	CbGeAlD
Lisinopril—ACE—blood vessel—leprosy	0.015	0.0756	CbGeAlD
Lisinopril—Dysaesthesia—Thalidomide—leprosy	0.0134	0.0167	CcSEcCtD
Lisinopril—ACE2—testis—leprosy	0.0134	0.0675	CbGeAlD
Lisinopril—ACE2—nervous system—leprosy	0.0131	0.0662	CbGeAlD
Lisinopril—Proteinuria—Dapsone—leprosy	0.0129	0.016	CcSEcCtD
Lisinopril—Protein urine present—Dapsone—leprosy	0.0127	0.0158	CcSEcCtD
Lisinopril—Cerebral ischaemia—Thalidomide—leprosy	0.012	0.0149	CcSEcCtD
Lisinopril—Transient ischaemic attack—Thalidomide—leprosy	0.0115	0.0143	CcSEcCtD
Lisinopril—Inappropriate antidiuretic hormone secretion—Thalidomide—leprosy	0.00995	0.0124	CcSEcCtD
Lisinopril—Serum creatinine increased—Thalidomide—leprosy	0.0094	0.0117	CcSEcCtD
Lisinopril—Psoriasis—Thalidomide—leprosy	0.0092	0.0115	CcSEcCtD
Lisinopril—Hyperlipidaemia—Thalidomide—leprosy	0.00802	0.01	CcSEcCtD
Lisinopril—ACE—eye—leprosy	0.00797	0.0402	CbGeAlD
Lisinopril—Pleural effusion—Thalidomide—leprosy	0.00755	0.00942	CcSEcCtD
Lisinopril—Nasopharyngitis—Dapsone—leprosy	0.00733	0.00914	CcSEcCtD
Lisinopril—Influenza—Dapsone—leprosy	0.00709	0.00884	CcSEcCtD
Lisinopril—Endocrine disorder—Thalidomide—leprosy	0.00698	0.0087	CcSEcCtD
Lisinopril—Pancreatitis—Dapsone—leprosy	0.00695	0.00866	CcSEcCtD
Lisinopril—Proteinuria—Thalidomide—leprosy	0.00658	0.00821	CcSEcCtD
Lisinopril—Jaundice cholestatic—Thalidomide—leprosy	0.00658	0.00821	CcSEcCtD
Lisinopril—Accidental injury—Thalidomide—leprosy	0.00654	0.00815	CcSEcCtD
Lisinopril—Protein urine present—Thalidomide—leprosy	0.00649	0.00809	CcSEcCtD
Lisinopril—Photosensitivity reaction—Dapsone—leprosy	0.00647	0.00807	CcSEcCtD
Lisinopril—Viral infection—Thalidomide—leprosy	0.0064	0.00798	CcSEcCtD
Lisinopril—Arthropathy—Thalidomide—leprosy	0.00636	0.00793	CcSEcCtD
Lisinopril—Oliguria—Thalidomide—leprosy	0.00627	0.00782	CcSEcCtD
Lisinopril—Drug interaction—Thalidomide—leprosy	0.00623	0.00777	CcSEcCtD
Lisinopril—Neuropathy peripheral—Dapsone—leprosy	0.00619	0.00772	CcSEcCtD
Lisinopril—Leukocytosis—Thalidomide—leprosy	0.00615	0.00767	CcSEcCtD
Lisinopril—Creatinine increased—Thalidomide—leprosy	0.00607	0.00758	CcSEcCtD
Lisinopril—Sinusitis—Dapsone—leprosy	0.00593	0.00739	CcSEcCtD
Lisinopril—Neck pain—Thalidomide—leprosy	0.00585	0.0073	CcSEcCtD
Lisinopril—Pulmonary embolism—Thalidomide—leprosy	0.00578	0.00721	CcSEcCtD
Lisinopril—Hyperkalaemia—Thalidomide—leprosy	0.00568	0.00708	CcSEcCtD
Lisinopril—Pharyngitis—Dapsone—leprosy	0.00563	0.00702	CcSEcCtD
Lisinopril—Blood urea increased—Thalidomide—leprosy	0.00546	0.00681	CcSEcCtD
Lisinopril—Neuropathy—Thalidomide—leprosy	0.00543	0.00677	CcSEcCtD
Lisinopril—Tinnitus—Dapsone—leprosy	0.00529	0.0066	CcSEcCtD
Lisinopril—ABCB1—blood vessel—leprosy	0.00527	0.0266	CbGeAlD
Lisinopril—Lightheadedness—Thalidomide—leprosy	0.00517	0.00645	CcSEcCtD
Lisinopril—Pulmonary oedema—Thalidomide—leprosy	0.00515	0.00642	CcSEcCtD
Lisinopril—Hypertonia—Thalidomide—leprosy	0.00507	0.00632	CcSEcCtD
Lisinopril—Erythema—Dapsone—leprosy	0.00494	0.00616	CcSEcCtD
Lisinopril—Diabetes mellitus—Thalidomide—leprosy	0.00483	0.00602	CcSEcCtD
Lisinopril—Photosensitivity—Thalidomide—leprosy	0.00478	0.00596	CcSEcCtD
Lisinopril—Gastroenteritis—Thalidomide—leprosy	0.00474	0.00591	CcSEcCtD
Lisinopril—Eczema—Thalidomide—leprosy	0.00467	0.00582	CcSEcCtD
Lisinopril—Vision blurred—Dapsone—leprosy	0.00465	0.0058	CcSEcCtD
Lisinopril—Injury—Thalidomide—leprosy	0.00457	0.00569	CcSEcCtD
Lisinopril—Renal failure acute—Thalidomide—leprosy	0.00455	0.00567	CcSEcCtD
Lisinopril—Libido decreased—Thalidomide—leprosy	0.00453	0.00564	CcSEcCtD
Lisinopril—Vertigo—Dapsone—leprosy	0.00444	0.00553	CcSEcCtD
Lisinopril—Atrial fibrillation—Thalidomide—leprosy	0.00443	0.00552	CcSEcCtD
Lisinopril—ACE—testis—leprosy	0.00437	0.0221	CbGeAlD
Lisinopril—Arthritis—Thalidomide—leprosy	0.00432	0.00539	CcSEcCtD
Lisinopril—Cough—Dapsone—leprosy	0.00431	0.00537	CcSEcCtD
Lisinopril—Hypoglycaemia—Thalidomide—leprosy	0.0043	0.00536	CcSEcCtD
Lisinopril—ACE—nervous system—leprosy	0.00429	0.0216	CbGeAlD
Lisinopril—Cerebrovascular accident—Thalidomide—leprosy	0.00428	0.00534	CcSEcCtD
Lisinopril—Hyponatraemia—Thalidomide—leprosy	0.00421	0.00526	CcSEcCtD
Lisinopril—Osteoarthritis—Thalidomide—leprosy	0.0042	0.00523	CcSEcCtD
Lisinopril—Diplopia—Thalidomide—leprosy	0.0042	0.00523	CcSEcCtD
Lisinopril—Pain in extremity—Thalidomide—leprosy	0.0042	0.00523	CcSEcCtD
Lisinopril—Disturbance in sexual arousal—Thalidomide—leprosy	0.00416	0.00519	CcSEcCtD
Lisinopril—Face oedema—Thalidomide—leprosy	0.00405	0.00505	CcSEcCtD
Lisinopril—Cardiac arrest—Thalidomide—leprosy	0.00399	0.00498	CcSEcCtD
Lisinopril—Ataxia—Thalidomide—leprosy	0.00395	0.00492	CcSEcCtD
Lisinopril—Tachycardia—Dapsone—leprosy	0.00393	0.0049	CcSEcCtD
Lisinopril—Blood creatinine increased—Thalidomide—leprosy	0.00393	0.0049	CcSEcCtD
Lisinopril—Dehydration—Thalidomide—leprosy	0.0039	0.00487	CcSEcCtD
Lisinopril—Orthostatic hypotension—Thalidomide—leprosy	0.00383	0.00478	CcSEcCtD
Lisinopril—Breast disorder—Thalidomide—leprosy	0.00379	0.00473	CcSEcCtD
Lisinopril—Toxic epidermal necrolysis—Thalidomide—leprosy	0.00378	0.00471	CcSEcCtD
Lisinopril—Cramp muscle—Thalidomide—leprosy	0.00378	0.00471	CcSEcCtD
Lisinopril—Insomnia—Dapsone—leprosy	0.00365	0.00455	CcSEcCtD
Lisinopril—Influenza—Thalidomide—leprosy	0.00363	0.00452	CcSEcCtD
Lisinopril—Eosinophilia—Thalidomide—leprosy	0.00359	0.00448	CcSEcCtD
Lisinopril—Bronchospasm—Thalidomide—leprosy	0.00357	0.00445	CcSEcCtD
Lisinopril—Pancreatitis—Thalidomide—leprosy	0.00356	0.00444	CcSEcCtD
Lisinopril—Angina pectoris—Thalidomide—leprosy	0.00353	0.00441	CcSEcCtD
Lisinopril—Bronchitis—Thalidomide—leprosy	0.00349	0.00435	CcSEcCtD
Lisinopril—Pancytopenia—Thalidomide—leprosy	0.00345	0.0043	CcSEcCtD
Lisinopril—Neutropenia—Thalidomide—leprosy	0.00339	0.00423	CcSEcCtD
Lisinopril—Upper respiratory tract infection—Thalidomide—leprosy	0.00337	0.0042	CcSEcCtD
Lisinopril—Erectile dysfunction—Thalidomide—leprosy	0.00334	0.00417	CcSEcCtD
Lisinopril—Photosensitivity reaction—Thalidomide—leprosy	0.00331	0.00413	CcSEcCtD
Lisinopril—Weight increased—Thalidomide—leprosy	0.0033	0.00412	CcSEcCtD
Lisinopril—Gastrointestinal pain—Dapsone—leprosy	0.0033	0.00411	CcSEcCtD
Lisinopril—Weight decreased—Thalidomide—leprosy	0.00328	0.00409	CcSEcCtD
Lisinopril—Hyperglycaemia—Thalidomide—leprosy	0.00327	0.00408	CcSEcCtD
Lisinopril—Pneumonia—Thalidomide—leprosy	0.00325	0.00406	CcSEcCtD
Lisinopril—Depression—Thalidomide—leprosy	0.00323	0.00402	CcSEcCtD
Lisinopril—Stevens-Johnson syndrome—Thalidomide—leprosy	0.00321	0.004	CcSEcCtD
Lisinopril—Acute coronary syndrome—Thalidomide—leprosy	0.00319	0.00398	CcSEcCtD
Lisinopril—Body temperature increased—Dapsone—leprosy	0.00319	0.00397	CcSEcCtD
Lisinopril—Abdominal pain—Dapsone—leprosy	0.00319	0.00397	CcSEcCtD
Lisinopril—Renal failure—Thalidomide—leprosy	0.00318	0.00397	CcSEcCtD
Lisinopril—Neuropathy peripheral—Thalidomide—leprosy	0.00317	0.00395	CcSEcCtD
Lisinopril—Myocardial infarction—Thalidomide—leprosy	0.00317	0.00395	CcSEcCtD
Lisinopril—Sweating—Thalidomide—leprosy	0.0031	0.00387	CcSEcCtD
Lisinopril—Haematuria—Thalidomide—leprosy	0.00308	0.00385	CcSEcCtD
Lisinopril—Epistaxis—Thalidomide—leprosy	0.00305	0.0038	CcSEcCtD
Lisinopril—Sinusitis—Thalidomide—leprosy	0.00303	0.00378	CcSEcCtD
Lisinopril—Agranulocytosis—Thalidomide—leprosy	0.00302	0.00376	CcSEcCtD
Lisinopril—Bradycardia—Thalidomide—leprosy	0.00296	0.00369	CcSEcCtD
Lisinopril—Rhinitis—Thalidomide—leprosy	0.00291	0.00363	CcSEcCtD
Lisinopril—Hepatitis—Thalidomide—leprosy	0.0029	0.00362	CcSEcCtD
Lisinopril—Pharyngitis—Thalidomide—leprosy	0.00288	0.00359	CcSEcCtD
Lisinopril—Urinary tract disorder—Thalidomide—leprosy	0.00287	0.00358	CcSEcCtD
Lisinopril—Oedema peripheral—Thalidomide—leprosy	0.00286	0.00357	CcSEcCtD
Lisinopril—Urethral disorder—Thalidomide—leprosy	0.00285	0.00355	CcSEcCtD
Lisinopril—Erythema multiforme—Thalidomide—leprosy	0.00275	0.00342	CcSEcCtD
Lisinopril—Tinnitus—Thalidomide—leprosy	0.00271	0.00338	CcSEcCtD
Lisinopril—Angiopathy—Thalidomide—leprosy	0.00263	0.00329	CcSEcCtD
Lisinopril—Mediastinal disorder—Thalidomide—leprosy	0.00262	0.00326	CcSEcCtD
Lisinopril—Chills—Thalidomide—leprosy	0.00261	0.00325	CcSEcCtD
Lisinopril—Arrhythmia—Thalidomide—leprosy	0.00259	0.00323	CcSEcCtD
Lisinopril—Alopecia—Thalidomide—leprosy	0.00257	0.0032	CcSEcCtD
Lisinopril—Vomiting—Dapsone—leprosy	0.00256	0.0032	CcSEcCtD
Lisinopril—Mental disorder—Thalidomide—leprosy	0.00254	0.00317	CcSEcCtD
Lisinopril—Malnutrition—Thalidomide—leprosy	0.00253	0.00315	CcSEcCtD
Lisinopril—Headache—Dapsone—leprosy	0.00252	0.00315	CcSEcCtD
Lisinopril—Flatulence—Thalidomide—leprosy	0.00249	0.00311	CcSEcCtD
Lisinopril—Tension—Thalidomide—leprosy	0.00248	0.00309	CcSEcCtD
Lisinopril—Dysgeusia—Thalidomide—leprosy	0.00248	0.00309	CcSEcCtD
Lisinopril—Nervousness—Thalidomide—leprosy	0.00246	0.00306	CcSEcCtD
Lisinopril—Back pain—Thalidomide—leprosy	0.00245	0.00305	CcSEcCtD
Lisinopril—Muscle spasms—Thalidomide—leprosy	0.00243	0.00303	CcSEcCtD
Lisinopril—Nausea—Dapsone—leprosy	0.00239	0.00299	CcSEcCtD
Lisinopril—Vision blurred—Thalidomide—leprosy	0.00238	0.00297	CcSEcCtD
Lisinopril—Tremor—Thalidomide—leprosy	0.00237	0.00295	CcSEcCtD
Lisinopril—Ill-defined disorder—Thalidomide—leprosy	0.00235	0.00292	CcSEcCtD
Lisinopril—Anaemia—Thalidomide—leprosy	0.00234	0.00291	CcSEcCtD
Lisinopril—Angioedema—Thalidomide—leprosy	0.00231	0.00288	CcSEcCtD
Lisinopril—Malaise—Thalidomide—leprosy	0.00228	0.00284	CcSEcCtD
Lisinopril—Vertigo—Thalidomide—leprosy	0.00227	0.00283	CcSEcCtD
Lisinopril—Syncope—Thalidomide—leprosy	0.00227	0.00283	CcSEcCtD
Lisinopril—Leukopenia—Thalidomide—leprosy	0.00226	0.00282	CcSEcCtD
Lisinopril—Palpitations—Thalidomide—leprosy	0.00223	0.00279	CcSEcCtD
Lisinopril—Loss of consciousness—Thalidomide—leprosy	0.00222	0.00277	CcSEcCtD
Lisinopril—Cough—Thalidomide—leprosy	0.00221	0.00275	CcSEcCtD
Lisinopril—Chest pain—Thalidomide—leprosy	0.00215	0.00268	CcSEcCtD
Lisinopril—Myalgia—Thalidomide—leprosy	0.00215	0.00268	CcSEcCtD
Lisinopril—Arthralgia—Thalidomide—leprosy	0.00215	0.00268	CcSEcCtD
Lisinopril—Anxiety—Thalidomide—leprosy	0.00214	0.00267	CcSEcCtD
Lisinopril—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.00214	0.00267	CcSEcCtD
Lisinopril—Discomfort—Thalidomide—leprosy	0.00213	0.00265	CcSEcCtD
Lisinopril—Dry mouth—Thalidomide—leprosy	0.0021	0.00262	CcSEcCtD
Lisinopril—Confusional state—Thalidomide—leprosy	0.00208	0.00259	CcSEcCtD
Lisinopril—Oedema—Thalidomide—leprosy	0.00206	0.00257	CcSEcCtD
Lisinopril—Infection—Thalidomide—leprosy	0.00205	0.00256	CcSEcCtD
Lisinopril—Shock—Thalidomide—leprosy	0.00203	0.00253	CcSEcCtD
Lisinopril—Thrombocytopenia—Thalidomide—leprosy	0.00202	0.00252	CcSEcCtD
Lisinopril—Tachycardia—Thalidomide—leprosy	0.00201	0.00251	CcSEcCtD
Lisinopril—Skin disorder—Thalidomide—leprosy	0.002	0.0025	CcSEcCtD
Lisinopril—Hyperhidrosis—Thalidomide—leprosy	0.00199	0.00249	CcSEcCtD
Lisinopril—Anorexia—Thalidomide—leprosy	0.00197	0.00245	CcSEcCtD
Lisinopril—Hypotension—Thalidomide—leprosy	0.00193	0.0024	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Thalidomide—leprosy	0.00188	0.00234	CcSEcCtD
Lisinopril—Insomnia—Thalidomide—leprosy	0.00187	0.00233	CcSEcCtD
Lisinopril—Paraesthesia—Thalidomide—leprosy	0.00185	0.00231	CcSEcCtD
Lisinopril—Dyspnoea—Thalidomide—leprosy	0.00184	0.00229	CcSEcCtD
Lisinopril—Somnolence—Thalidomide—leprosy	0.00183	0.00229	CcSEcCtD
Lisinopril—Dyspepsia—Thalidomide—leprosy	0.00182	0.00226	CcSEcCtD
Lisinopril—Decreased appetite—Thalidomide—leprosy	0.00179	0.00224	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Thalidomide—leprosy	0.00178	0.00222	CcSEcCtD
Lisinopril—Fatigue—Thalidomide—leprosy	0.00178	0.00222	CcSEcCtD
Lisinopril—Pain—Thalidomide—leprosy	0.00176	0.0022	CcSEcCtD
Lisinopril—Constipation—Thalidomide—leprosy	0.00176	0.0022	CcSEcCtD
Lisinopril—Feeling abnormal—Thalidomide—leprosy	0.0017	0.00212	CcSEcCtD
Lisinopril—Gastrointestinal pain—Thalidomide—leprosy	0.00169	0.0021	CcSEcCtD
Lisinopril—Urticaria—Thalidomide—leprosy	0.00164	0.00204	CcSEcCtD
Lisinopril—Body temperature increased—Thalidomide—leprosy	0.00163	0.00203	CcSEcCtD
Lisinopril—Abdominal pain—Thalidomide—leprosy	0.00163	0.00203	CcSEcCtD
Lisinopril—ABCB1—testis—leprosy	0.00154	0.00777	CbGeAlD
Lisinopril—Hypersensitivity—Thalidomide—leprosy	0.00152	0.0019	CcSEcCtD
Lisinopril—ABCB1—nervous system—leprosy	0.00151	0.00762	CbGeAlD
Lisinopril—Asthenia—Thalidomide—leprosy	0.00148	0.00185	CcSEcCtD
Lisinopril—Pruritus—Thalidomide—leprosy	0.00146	0.00182	CcSEcCtD
Lisinopril—Diarrhoea—Thalidomide—leprosy	0.00141	0.00176	CcSEcCtD
Lisinopril—Dizziness—Thalidomide—leprosy	0.00136	0.0017	CcSEcCtD
Lisinopril—Vomiting—Thalidomide—leprosy	0.00131	0.00164	CcSEcCtD
Lisinopril—Rash—Thalidomide—leprosy	0.0013	0.00162	CcSEcCtD
Lisinopril—Dermatitis—Thalidomide—leprosy	0.0013	0.00162	CcSEcCtD
Lisinopril—Headache—Thalidomide—leprosy	0.00129	0.00161	CcSEcCtD
Lisinopril—Nausea—Thalidomide—leprosy	0.00123	0.00153	CcSEcCtD
